Dr.Benjamin E Blass and Dr. Daniel J Canney receive grant from the Crohn's & Colitis Foundation
Dr.Benjamin E Blass and Dr. Daniel J Canney received grant from the Crohn's & Colitis Foundation to study the role of the 5-HT7 receptor in inflammatory bowel disease (IBD). The three year, $347,490 program entitled “Novel Therapies for the Treatment of Ulcerative Colitis: 5-HT7 Antagonists" will also include Dr. Waliul Khan from McMaster University. Dr. Khan is a leading expert in IBD animal models and pharmacology.
Moulder Center for Drug Discovery Research
Temple University School of Pharmacy 3307 N Broad Street Philadelphia, PA 19140